Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
103 hedge funds and large institutions have $191M invested in Tetraphase Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 12 closing their positions.
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
22% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 27
10% more funds holding
Funds holding: 94 → 103 (+9)
7% less capital invested
Capital invested by funds: $204M → $191M (-$13.6M)
52% less call options, than puts
Call options by funds: $840K | Put options by funds: $1.75M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.53M |
| 2 |
Millennium Management
New York
|
+$4.09M |
| 3 |
Renaissance Technologies
New York
|
+$1.66M |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$1.03M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$890K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.91M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$684K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$676K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$384K |
TTPH Hedge Fund Activity: Q4 2017 in Review
103 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q4 2017, worth a combined $191M — down 6.6% from $204M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new TTPH positions and 12 closed out — a net gain of 10 holders — while 33 added to existing stakes and 27 trimmed.
The largest buyer was BlackRock, adding an estimated $4.53M. The largest seller was Wellington Management Group, exiting entirely with an estimated $11.5M sold.
- 103 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q4 2017, up from 94 in Q3 2017.
- Funds reported $191M of Tetraphase Pharmaceuticals, Inc. stock for Q4 2017, down 6.6% quarter-over-quarter.
- 22 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q4 2017 and 12 closed out, a net change of +10 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q4 2017 was BlackRock, an estimated $4.53M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q4 2017 was Wellington Management Group, an estimated $11.5M sold.
Based on aggregated 13F filings for Q4 2017.